| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/10/2004 | US6773723 Collagen/polysaccharide bilayer matrix |
| 08/10/2004 | US6773709 Chicken embryo lethal (CELO) virus |
| 08/10/2004 | US6773707 Employing hybrid antigen complex |
| 08/10/2004 | US6773705 Restoring nf kappa b activity |
| 08/07/2004 | CA2457105A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/05/2004 | WO2004065932A2 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 08/05/2004 | WO2004065636A1 Solid surface for biomolecule delivery and high-throughput assay |
| 08/05/2004 | WO2004065621A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 08/05/2004 | WO2004065581A2 Transposon-insulator element delivery systems |
| 08/05/2004 | WO2004065580A2 Mesecnhymal stem cells as a vehicle for ion channel transfer in syncytial structures |
| 08/05/2004 | WO2004065578A2 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
| 08/05/2004 | WO2004065549A2 Small interference rna gene therapy |
| 08/05/2004 | WO2004065440A2 Cationic graft-copolymer for non-viral gene delivery vector |
| 08/05/2004 | WO2004064868A1 Tarp promoter and uses thereof |
| 08/05/2004 | WO2004064856A2 Proteins involved in the regulation of energy homeostasis |
| 08/05/2004 | WO2004064785A2 Cancer therapy sensitizer |
| 08/05/2004 | WO2004064782A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 08/05/2004 | WO2004064776A2 Methods of preparation of live attenuated bacterial vaccines by alteration of dna adenine methylase (dam) activity in those bacteria |
| 08/05/2004 | WO2004064773A2 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders |
| 08/05/2004 | WO2004064765A2 Herpesvirus amplicon particles |
| 08/05/2004 | WO2004064763A2 Cleavage of serum response factor in cardiac diagnosis and therapy |
| 08/05/2004 | WO2004064750A2 Improved constructs for expressing lysosomal polypeptides |
| 08/05/2004 | WO2004064711A2 Modulation of deubiquitinase family members |
| 08/05/2004 | WO2004064501A2 Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins |
| 08/05/2004 | WO2004043370A3 Methods and compositions for modulating activator protein 1 |
| 08/05/2004 | WO2004041200A3 Dna based plasmid formulations and vaccines and prophylactics containing the same |
| 08/05/2004 | WO2004037976A3 NONSENSE-MEDIATED mRNA DECAY |
| 08/05/2004 | WO2004029246A3 Integrase cofactor |
| 08/05/2004 | WO2004028339A3 Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004020465A3 Proteins involved in the regulation of energy homeostasis |
| 08/05/2004 | WO2003104392A3 Improved reagents and methods for producing parvoviruses |
| 08/05/2004 | WO2003102173A8 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances |
| 08/05/2004 | WO2003054512A3 Identification of an amplified gene and target for drug intervention |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003037165A3 System and method for the pretreatment of the endplates of an intervertebral disc |
| 08/05/2004 | WO2002101357A3 Molecular signatures of commonly fatal carcinomas |
| 08/05/2004 | US20040152883 Tocopherol associated protein and uses thereof |
| 08/05/2004 | US20040152875 Novel purinergic receptor |
| 08/05/2004 | US20040152873 Novel gene bn01 mapping to chromosone 16q24.3 |
| 08/05/2004 | US20040152658 For therapy of animal having a deficiency in a neuron's immediate early gene responsiveness to a stimulus |
| 08/05/2004 | US20040152655 Antisense oligonucleotides that inhibit expression of HIF-1 |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152652 Therapy of inflammatory disorder in an individual comprising administering oligonucleotide up to 30 nucleotides in length complementary to a nucleic acid molecule encoding human tumor necrosis factor- alpha |
| 08/05/2004 | US20040152647 For use in gene therapy |
| 08/05/2004 | US20040152639 Peptide hormone analogs of GnRH designed to be useful in male and female fertility regulation, post-coital contraception and as a menses-inducing agent, for managing ovarian cyst, polycystic ovarian disease, in vitro fertilization |
| 08/05/2004 | US20040152626 Identification of novel splice variants of the human catalytic subunit cbeta of camp-dependent protein kinase and the use thereof |
| 08/05/2004 | US20040152195 Vector for introducing molecules in eukaryotic cells and molecules vectorised by same |
| 08/05/2004 | US20040152189 Transgenic embryonic progenitor cell which comprises nucleotide sequences coding octamer binding transcription factor 4 (OCT-4) promoter and a galactosyltransferase for use in tissue targeted therapy, drug screening and regeneration medicine |
| 08/05/2004 | US20040152169 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
| 08/05/2004 | US20040152168 Genetically engineered cells comprising expression vectgor coding transcription factor polypeptide for use in transformation of stem cells and generation of pancreatic tissue; insulin delivery tool and diabetes treatment |
| 08/05/2004 | US20040152164 62 human secreted proteins |
| 08/05/2004 | US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152138 Using dementia related osteoponton (DROPN) peptides to diagnose, prognose and identify treatments for progressive neurodegenerative diseases |
| 08/05/2004 | US20040152112 Compositions and methods for cancer diagnosis and therapy |
| 08/05/2004 | US20040152111 Compositions and methods for diagnosing and treating mood disorders |
| 08/05/2004 | US20040152098 Cellular signal-responsive gene transcriptional regulation system |
| 08/05/2004 | US20040152092 Cancer therapy, cardiovascular disorders, central nervous system disorders, asthma, antidiabetic agents |
| 08/05/2004 | US20040152088 Methods for diagnosing and treating heart disease |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040152073 Human cellular protein gastrointestinal glutathione peroxidase active materials |
| 08/05/2004 | US20040152069 Synthetic gagpol genes and their uses |
| 08/05/2004 | US20040151779 suspending an active agent-containing powder with active agent hydration less than about 10% in at least one anhydrous, aprotic, hydrophobic, non-polar, low-reactivity vehicle; useful to delivery to an animal for sustained release for long term treatment |
| 08/05/2004 | US20040151707 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same |
| 08/05/2004 | CA2802143A1 Cancer therapy sensitizer |
| 08/05/2004 | CA2553313A1 Cationic graft-copolymer for non-viral gene delivery vector |
| 08/05/2004 | CA2513679A1 Small interference rna gene therapy |
| 08/05/2004 | CA2513675A1 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 08/05/2004 | CA2513559A1 Herpesvirus amplicon particles |
| 08/05/2004 | CA2513470A1 Modulation of deubiquitinase family members |
| 08/05/2004 | CA2513418A1 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
| 08/05/2004 | CA2513182A1 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders |
| 08/05/2004 | CA2513044A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 08/05/2004 | CA2512144A1 Solid surface for biomolecule delivery and high-throughput assay |
| 08/04/2004 | EP1443438A1 Dna providing system |
| 08/04/2004 | EP1443110A2 Human VEGF-specific antisense oligonucleotides |
| 08/04/2004 | EP1443051A2 Sugar modified oligonucleotides that detect and modulate gene expression |
| 08/04/2004 | EP1442750A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 08/04/2004 | EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/04/2004 | EP1442140A2 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 08/04/2004 | EP1442132A2 Methods for the treatment of osteoarthritis and compositions thereof |
| 08/04/2004 | EP1442125A2 Chimeric viral vectors for gene therapy |
| 08/04/2004 | EP1442060A2 A novel g protein-coupled receptor, gave 10 |
| 08/04/2004 | EP1442057A1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy |
| 08/04/2004 | EP1442022A2 Polyamide modulators of cox2 transcription |
| 08/04/2004 | EP1441762A1 Rsv gene expression vaccine |
| 08/04/2004 | EP1441760A2 Anthrax antigenic compositions |
| 08/04/2004 | EP1441752A1 Endophilin homologous proteins involved in the regulation of energy homeostasis |
| 08/04/2004 | EP1441743A2 Methods for treating ocular neovascular diseases |
| 08/04/2004 | EP1441742A2 Axon repair |
| 08/04/2004 | EP1441684A2 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524 |
| 08/04/2004 | EP1441682A1 Method to induce neovascular formation and tissue regeneration |
| 08/04/2004 | EP1441656A1 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/04/2004 | EP1313772B1 New cross-linked derivatives of hyaluronic acid |
| 08/04/2004 | EP1171151A4 Thrombospondin-2 and uses thereof |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1165140B1 Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1126879A4 Gene therapy for regulating smooth muscle cell tone |